OBJECTIVE: To explore how individuals respond to global coronary heart disease (CHD) risk and use it in combination with treatment information to make decisions to initiate and maintain risk reducing strategies. METHODS: We conducted four focus groups of individuals at risk for CHD (n=29), purposively sampling individuals with each of several risk factors. Two reviewers coded verbatim transcripts and arbitrated differences, using ATLAS.ti 5.2 to facilitate analysis. RESULTS: Participants generally regarded the concept of global CHD risk as useful and motivating, although had questions about its precision and comprehensiveness. They identified several additional influential factors in decision-making (e.g. achievable risk, the quickness and self-evidence of results) and generally preferred lifestyle changes to medications (although most would accept medications under certain circumstances). They also noted the importance of participating in decision-making. CONCLUSION: Our results underscore the motivating potential of global CHD risk and the importance of patient participation in decision-making. PRACTICE IMPLICATIONS: Global CHD risk is a useful adjunct to CHD prevention and can be presented in ways, and with information, that might improve CHD outcomes.
OBJECTIVE: To explore how individuals respond to global coronary heart disease (CHD) risk and use it in combination with treatment information to make decisions to initiate and maintain risk reducing strategies. METHODS: We conducted four focus groups of individuals at risk for CHD (n=29), purposively sampling individuals with each of several risk factors. Two reviewers coded verbatim transcripts and arbitrated differences, using ATLAS.ti 5.2 to facilitate analysis. RESULTS:Participants generally regarded the concept of global CHD risk as useful and motivating, although had questions about its precision and comprehensiveness. They identified several additional influential factors in decision-making (e.g. achievable risk, the quickness and self-evidence of results) and generally preferred lifestyle changes to medications (although most would accept medications under certain circumstances). They also noted the importance of participating in decision-making. CONCLUSION: Our results underscore the motivating potential of global CHD risk and the importance of patient participation in decision-making. PRACTICE IMPLICATIONS: Global CHD risk is a useful adjunct to CHD prevention and can be presented in ways, and with information, that might improve CHD outcomes.
Authors: David Edelman; Eugene Z Oddone; Richard S Liebowitz; William S Yancy; Maren K Olsen; Amy S Jeffreys; Samuel D Moon; Amy C Harris; Linda L Smith; Ruth E Quillian-Wolever; Tracy W Gaudet Journal: J Gen Intern Med Date: 2006-07 Impact factor: 5.128
Authors: Glyn Elwyn; Annette O'Connor; Dawn Stacey; Robert Volk; Adrian Edwards; Angela Coulter; Richard Thomson; Alexandra Barratt; Michael Barry; Steven Bernstein; Phyllis Butow; Aileen Clarke; Vikki Entwistle; Deb Feldman-Stewart; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Nora Moumjid; Al Mulley; Cornelia Ruland; Karen Sepucha; Alan Sykes; Tim Whelan Journal: BMJ Date: 2006-08-14
Authors: Ben van Steenkiste; Trudy van der Weijden; Daniëlle Timmermans; Jaqueline Vaes; Jelle Stoffers; Richard Grol Journal: Patient Educ Couns Date: 2004-11
Authors: Audrey J Weymiller; Victor M Montori; Lesley A Jones; Amiram Gafni; Gordon H Guyatt; Sandra C Bryant; Teresa J H Christianson; Rebecca J Mullan; Steven A Smith Journal: Arch Intern Med Date: 2007-05-28
Authors: Stacey L Sheridan; Jennifer M Griffith; Lindy Behrend; Ziya Gizlice; Michael P Pignone Journal: Med Decis Making Date: 2010-05-18 Impact factor: 2.583
Authors: Felicity Goodyear-Smith; Timothy Kenealy; Susan Wells; Bruce Arroll; Margaret Horsburgh Journal: Ann Fam Med Date: 2011 Mar-Apr Impact factor: 5.166
Authors: Stacey L Sheridan; Lindy B Draeger; Michael P Pignone; Philip D Sloane; Carmen Samuel-Hodge; Eric A Finkelstein; Ziya Gizlice; Maihan B Vu; Daniel P Gitterman; Shrikant I Bangdiwala; Katrina E Donahue; Kelly Evenson; Alice S Ammerman; Thomas C Keyserling Journal: Contemp Clin Trials Date: 2013-08-02 Impact factor: 2.226
Authors: Stacey L Sheridan; Lindy B Draeger; Michael P Pignone; Thomas C Keyserling; Ross J Simpson; Barbara Rimer; Shrikant I Bangdiwala; Jianwen Cai; Ziya Gizlice Journal: BMC Health Serv Res Date: 2011-12-05 Impact factor: 2.655
Authors: Barbora Silarova; Joanne Lucas; Adam S Butterworth; Emanuele Di Angelantonio; Christine Girling; Kathryn Lawrence; Stuart Mackintosh; Carmel Moore; Rupert A Payne; Stephen J Sharp; Guy Shefer; Zoe Tolkien; Juliet Usher-Smith; Matthew Walker; John Danesh; Simon Griffin Journal: BMC Public Health Date: 2015-09-07 Impact factor: 3.295